1. Home
  2. ARTL vs IVP Comparison

ARTL vs IVP Comparison

Compare ARTL & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.84

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Logo Inspire Veterinary Partners Inc.

IVP

Inspire Veterinary Partners Inc.

HOLD

Current Price

$0.11

Market Cap

2.9M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
IVP
Founded
2011
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
2.9M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ARTL
IVP
Price
$1.84
$0.11
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
1.3M
71.8M
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,560,011.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.52
$0.10
52 Week High
$28.60
$6.31

Technical Indicators

Market Signals
Indicator
ARTL
IVP
Relative Strength Index (RSI) 33.96 21.36
Support Level $1.62 $0.12
Resistance Level $1.98 $0.14
Average True Range (ATR) 0.19 0.07
MACD 0.11 -0.01
Stochastic Oscillator 69.53 2.91

Price Performance

Historical Comparison
ARTL
IVP

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Share on Social Networks: